Bristol_Myers_Squibb - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

BMS reports mixed results for Opdivo in lung cancer trial

Bristol_Myers_Squibb
BMS’ Opdivo combination yields mixed results in patients with advanced NSCLC. Credit: Rept0n1x.